Welcome to the Online CME Course for Selected Articles from Prevention in the Care Setting
This online course was adopted from the Prevention in the Care Setting workshop that was held on October 12, 2006 in conjunction with the Annual Meeting of the Infectious Diseases Society of America. The workshop was co-organized by the National Network of STD/HIV Prevention Training Centers, the California STD/HIV Prevention Training Center and the HIV Medicine Association.
About the Course
This course is designed to help clinicians gain perspective on pressing issues surrounding HIV prevention in the HIV care setting and increase their knowledge regarding the management of sexually transmitted diseases in the HIV care setting. The recommended audience is clinicians that treat and manage patients with HIV/AIDS.
Credit Designation Statement
IDSA designates this educational activity for a maximum of 3
AMA PRA Category 1 Credit(s)™. This is based on the estimated time for completion. Physicians should claim credit commensurate with the extent of their participation in the activity.
Learning Objectives for HIV Prevention in the Care Setting
Upon completion of this educational activity, the reader should be able to:
- Describe updated CDC recommendations for the initial HIV screening
- Understand the relationship between acute HIV infection and the risk of transmission
- State the association between rectal STD infections and HIV risk
Learning Objectives for 2006 STD Treatment Guidelines Forum
Upon completion of this educational activity, the participant should be able to:
- Describe the recommended components of an initial STD screening for HIV-positive or MSM patients
- State the recommended alternative syphillis treatments for penicillin-allergic patients
- Identify the portion of anal cancer cases that are attributable to HPV
Faculty
Gail Bolan, MD, Chief of the California Department of Health Services STD Control Branch, Principal Investigator, California STD/HIV Prevention Training Center. No financial relationships to report.
Myron Cohen, MD, Professor of Medicine, Microbiology and Immunology and Epidemiology at the University of North Carolina at Chapel Hill. Dr. Cohen has served on the GSK speakers’ bureau.
Christopher Hall, MD, Deputy Director, California STD/HIV Prevention Training Center and Chief of Clinical Affairs, California Department of Health Services STD Control Branch. No financial relationships to report.
Peter Leone, MD, Associate Professor of Medicine, Associate Professor of Epidemiology, University of North Carolina at Chapel Hill. Dr. Leone has received funding for studies from GlaxoSmithKline and Novartis. He also has served on the GSK and Novartis speakers' bureaus and served as a consultant to GSK, Novartis, Abbott and GenProbe.
Jeanne Marrazzo, MD, MPH, Associate Professor of Medicine, Infectious Diseases Division, University of Washington, Medical Director, Seattle STD/HIV Prevention Training Center. Dr. Marrazzo has received a research grant from Presutti Laboratories and speakers' honorarium from Merck and 3M.
Joel Palefsky, MD, CM, Professor of Medicine, Associate Dean for Clinical and Translational Research, University of California, San Francisco, School of Medicine. No financial relationships to report.
Mark Thrun, MD, Assistant Professor of Medicine, Division of Infectious Diseases, University of Colorado Health Sciences Center. No financial relationships to report.
Kim Workowski, MD, FACP, Associate Professor of Medicine, Division of Infectious Diseases, Emory University. No financial relationships to report.
The cost of developing this continuing medical education program was supported by the HIV Prevention with National Medical and Nursing Associations Cooperative Agreement (Number U65/CCU324394-01) from the Centers for Disease Control and Prevention (CDC). The contents are solely the responsibility of the authors and do not necessarily represent the official views of the CDC.